Related Experiment Video
Updated: Jul 30, 2025

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
Hydralazine-Associated Vasculitis and Pulmonary Hemorrhage
Kateryna Strubchevska1, Marko Kozyk1, Matthew R Jacobs1
1Internal Medicine, Beaumont Hospital, Royal Oak, USA.
Hydralazine, a hypertension drug, can rarely cause autoimmune vasculitis. This case highlights hydralazine-associated vasculitis and pulmonary hemorrhage, emphasizing the need for awareness.
Area of Science:
- Rheumatology
- Nephrology
- Pulmonology
Background:
- Hydralazine is a vasodilator medication for hypertension.
- Rarely, it can induce antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
- This vasculitis may manifest as a pulmonary-renal syndrome.
More Related Videos
07:41Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
Published on: March 17, 2022
07:29The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
Published on: March 8, 2019
Related Concept Videos
Antihypertensive Drugs: Vasodilators
Rheumatic Heart Disease I: Introduction
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Heart Failure III: Clinical Manifestations
Rheumatic Heart Disease IV: Nursing Management